AlzChem Group AG Stock
Price
Target price
€44.20
€44.20
-1.340%
-0.6
-1.340%
€50.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock AlzChem Group AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for AlzChem
sharewise wants to provide you with the best news and tools for AlzChem, so we directly link to the best financial data sources.
Financials
News
EQS-News: Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
EQS-News: Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creatine supplementation
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creatine supplementation
Alzchem Group AG awarded for sustainable supply chains: Outstanding result certified by 'Together for Sustainability (TfS)' initiative
Alzchem Group AG awarded for sustainable supply chains: Outstanding result certified by 'Together for Sustainability (TfS)' initiative
EQS-News: Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024
EQS-News: Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024